Dyspnoea Exertional
also: Dyspnea Exertional
15 drugs15,718 FAERS reportsMedDRA PT
GET
/api/v1/reaction/dyspnoea-exertionalReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
Drugs reporting Dyspnoea Exertional (15)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Cystine133%
- 2Bexagliflozin312%
- 3Epoprostenol9627.5%
- 4Aprocitentan17.1%
- 5Riociguat1,5324.8%
- 6Selexipag1,2034.8%
- 7Sotatercept1744.5%
- 8Macitentan2,5163.7%
- 9Zafirlukast313.6%
- 10Nintedanib1,0643.6%
- 11Desipramine493.5%
- 12Oxygen1,6283.5%
- 13Treprostinil4,1723.4%
- 14Tadalafil2,3812.4%
- 15Telisotuzumab12.2%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Pulmonary Arterial Hypertension5 shared · 0.25
- Pain In Jaw4 shared · 0.24
- Fluid Retention6 shared · 0.19
- Cardiac Murmur2 shared · 0.13
- Oxygen Saturation Decreased6 shared · 0.10
- Flushing5 shared · 0.07
- Chest Pain8 shared · 0.05
- Productive Cough2 shared · 0.05
- Epistaxis2 shared · 0.05
- Hospitalisation5 shared · 0.04
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.